Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Joe Biden raised Canadian Sikh’s death with India’s Narendra Modi at G20
    • The decoy weapons leading Russian forces astray in Ukraine
    • F-35 fighter jets can only fly 55% of time, US watchdog says
    • India stops issuing visas to Canadians as row escalates
    • Russian state TV promotes new Tucker Carlson show
  • UK
    Sections
    • UK Home
    • UK Economy
    • UK Politics
    • Brexit
    • UK Companies
    • Personal Finance
    Most Read
    • Rishi Sunak plans to overhaul A-level system with ‘British baccalaureate’
    • Jeremy Hunt plans Isa overhaul to boost share ownership
    • UK recession risk increases as services activity falls
    • UK mortgage rates set to fall after Bank of England knife-edge vote
    • Number of UK nursing students plummets despite NHS shortages
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Asahi chief warns climate change could lead to beer shortages
    • Rupert Murdoch resolves his own succession drama — for now
    • Crispin Odey faces first lawsuit over alleged sexual misconduct
    • FTC lawsuit targets serial acquisitions by private equity
    • Silchester-backed asset management boutique shuts its doors
  • Tech
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Cryptofinance
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    Most Read
    • Live news: Fed officials ‘not ready to declare victory’ and signal more rate rises
    • Jeremy Hunt plans Isa overhaul to boost share ownership
    • How Xi Jinping is taking control of China’s stock market
    • Monzo clients rush to sign up for BlackRock offering
    • Russia puts squeeze on oil market with diesel export ban
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • Lex
    • Obituaries
    • Letters
    Most Read
    • How to save your state pension
    • Russell Brand learnt his tricks in television studios
    • Are we destined for a zero-sum future?
    • Lachlan’s accession won’t put an end to Murdoch family strife
    • Rachel Reeves: From the OBR to new fiscal rules, we will bring back stability
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    Most Read
    • ‘There is no work to balance’: how shrinking budgets, Covid and AI shook up life in consulting
    • American Express’s Steve Squeri: ‘If you’re not ready for the upswing, you’ve missed’
    • FT Business Books — what to read this month
    • Can I start a business when I have MS?
    • The plight of the hidden carers in your workforce
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • Anna Wintour: ‘I just have to make sure things are being done right’
    • Who’d invite the boss to dinner?
    • Bosses won’t like it but WFH is a happier way to work
    • PowerPoint is widely reviled. How did it triumph?
    • Should you buy the iPhone 15 Pro Max?
  • HTSI
MenuSearch
  • Home
  • World
  • UK
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Work & Careers
  • Life & Arts
  • HTSI
Financial Times
SubscribeSign In

Genomics

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Tuesday, 19 September, 2023
    Artificial intelligence
    DeepMind uses AI to predict harmful genetic mutations in humans

    First example of artificial intelligence helping to accelerate diagnosis of diseases caused by genetic variants

    An artist’s illustration of how artificial intelligence can predict patterns in biology
  • Monday, 21 August, 2023
    Medical science
    UK leads in genomic sequencing but must invest more, warns top scientist

    Suggestion opportunities yielded by lower cost of technology are not adequately recognised by government

    Research assistants work at sequencing machines analysing the genetic material of Covid-19 cases at the Wellcome Sanger Institute in Cambridgeshire
  • Thursday, 1 June, 2023
    ‘Primate AI algorithm’ predicts genetic health risks

    Scientists apply deep learning to expanded DNA database to help identify disease-causing mutations in humans

    Owl monkeys in Argentina
  • Wednesday, 10 May, 2023
    Expanded ‘pan-genome’ database aims to improve treatment of diseases

    Project discovers more variation in DNA than expected, offering insights into human diversity

    The pan-genome is presented in the form of a tube map
  • Wednesday, 12 April, 2023
    Medical science
    Genetic profile of lung cancer can predict disease’s next move

    UK scientists carry out most comprehensive study so far of tumour evolution and its implications for treatment

    Lung cancer cells under the microscope
  • Wednesday, 5 April, 2023
    Anjana Ahuja
    We should learn from rival attempts to write pandemic history

    Data-sharing was messy, as shown by duelling claims about who published the coronavirus genome sequence first 

    Andy Carter illustration of two people in white coats wrestling with a flag with a genome on it while standing on a coronavirus cell
  • Monday, 13 March, 2023
    Illumina Inc
    Carl Icahn takes aim at genome sequencer Illumina over Grail deal

    Company’s shares jump after activist investor launches proxy battle

    Carl Icahn
  • Wednesday, 8 March, 2023
    Cost of gene treatments for once incurable diseases too high, scientists warn

    Therapies based on editing of human genomes predicted to have a price tag of $2mn per patient

    Lab worker prepares vial
  • Wednesday, 8 March, 2023
    UK politics
    Chinese genomics company accused of hack attempts by UK minister

    Government later says no ‘evidence’ of attempted hacking of NHS genetic data centre by BGI

  • Tuesday, 7 March, 2023
    Anjana Ahuja
    We need rules before we let the genome-editing genie out of the bottle

    Changing human DNA brings hope for treating diseases but raises concerns such as equitable access

    Andy Carter illustration of a person standing in front of a gate depicted as a human genome  with parts of the body being upgraded
  • Monday, 6 March, 2023
    Chris Miller
    There’s a new US national security obsession — biotech

    The ability to apply massive computing power to DNA is causing concern over biological warfare

    Spiral strand of DNA on the dark background
  • Tuesday, 31 January, 2023
    Anjana Ahuja
    Dead as a dodo? The unsettling bid to bring back extinct species

    We should focus on conserving endangered animals rather than resurrecting those already gone

    Andy Carter illustration of scientists building a huge dodo
  • Sunday, 29 January, 2023
    News in-depthIllumina Inc
    Has Illumina taken the wrong path in its Grail quest?

    DNA sequencing expert’s investors question acquisition of cancer testing group that has also angered EU regulators

    Francis deSouza
  • Friday, 6 January, 2023
    Medical science
    UK signs deal with BioNTech for cutting-edge cancer trials

    Covid-19 vaccine maker hails ‘huge’ investment aimed at recruiting 10,000 participants with NHS

    An employee holds up a vial of an oncological product under development at the BioNTech’s research institute in Mainz, Germany
  • Friday, 30 December, 2022
    UK to embark on groundbreaking new genomics projects

    Programmes involving millions of volunteers will cement Britain’s place as leader in DNA research

    A baby and a double-helix of DNA
  • Tuesday, 13 December, 2022
    100,000 newborn babies set to have their DNA fully decoded

    Genomics England programme aims to extend the number of treatable conditions detected to about 200

    A mother holds her newborn baby
  • Thursday, 10 November, 2022
    The Big Read
    Mood shifts on gene-edited crops as droughts and wars bite

    The European Commission is considering easing regulation on the technology. But critics say it is an untested risk being pushed by Big Ag

    Farmer Hendrik Jan ten Cate looks down at some grass he is holding
  • Monday, 3 October, 2022
    Nobel prizes
    Swedish geneticist wins Nobel prize for decoding DNA of human ancestors

    Svante Pääbo’s sequencing of the Neanderthal’s genome boosts understanding of evolution

    Svante Pääbo
  • Tuesday, 16 August, 2022
    Scientists vow to bring Tasmanian tiger back from extinction

    US biotech behind project to recreate woolly mammoth turns its attention to thylacine

    Black and white image of two Tasmanian tigers in Hobart Zoo in 1933
  • Sunday, 14 August, 2022
    Biotech
    Cambridge start-up aims to rewrite the code of life

    Constructive Bio plans to reprogramme microbes to make new materials from drugs to biodegradable plastics

    Three synthetic bacteria with reprogrammed genetic code
  • Thursday, 28 July, 2022
    Medical science
    First genetic treatment for inherited heart disease receives £30mn funding

    Injectable cure for congenital cardiomyopathies could be available within a few years, says UK charity

  • Tuesday, 24 May, 2022
    Agritech
    Plant scientists welcome UK bill to deregulate crop engineering

    Campaigners warn against loosening of gene editing rules made possible by Brexit

    Scientists Nigel Halford and Sarah Raffan examine gene-edited wheat at Rothamsted Research in Harpenden
  • Sunday, 13 March, 2022
    ExplainerCoronavirus
    How can genomic sequencing spot the next coronavirus variant?

    Discovery of new strain that combines elements of Delta and Omicron shows importance of surveillance

    Montage of test tubes and RNA
  • Monday, 7 March, 2022
    Coronavirus treatment
    Scientists identify genetic factors behind severe Covid

    Sixteen genes that predispose people to critical illness pinpointed in world’s largest study of its kind

    A healthcare worker tends to a Covid-19 patient at an intensive care unit in Barcelona
  • Wednesday, 9 February, 2022
    ReviewNon-Fiction
    Control by Adam Rutherford — the past and present dangers of eugenics

    The broadcaster and geneticist takes a clear-sighted look at a troublesome ideology

Previous page You are on page 1 Next page

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsProfessional SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on XFT ChannelsFT Schools

Tools

PortfolioToday’s Newspaper (FT Digital Edition)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

Community & Events

FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

UK Edition

Subscribe for full access
  • Switch to International Edition

Top sections

  • Home
  • World
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
  • UK
    • UK Economy
    • UK Politics
    • Brexit
    • UK Companies
    • Personal Finance
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
  • Markets
    • Alphaville
    • Markets Data
    • Cryptofinance
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • Lex
    • Obituaries
    • Letters
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • HTSI
  • Special Reports

FT recommends

  • Lex
  • Alphaville
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • Visual and data journalism
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • FT Live Events
  • FT Forums
  • Board Director Programme
  • myFT
  • Portfolio
  • Today’s Newspaper (FT Digital Edition)
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In